Insider Transactions
Showing insider trading activity for Wigginton Jon Marc.
Insider Trading Activity Chart
Visualizing insider transactions on stock price candles
Transaction Type
Insider Role
Min Transaction Value
No stock price data available.
Recent Filings
| Symbol | Name | Filed | Transaction | Type | Role | Shares |
|---|---|---|---|---|---|---|
| STRO | Wigginton Jon Marc | 29 Dec 2025 | 23 Dec 2025 | A-Award | director | 1,500 |
| STRO | Wigginton Jon Marc | 10 Jun 2025 | 6 Jun 2025 | A-Award | director | 50,000 |
| STRO | Wigginton Jon Marc | 10 Jun 2024 | 6 Jun 2024 | A-Award | director | 35,000 |
| STRO | Wigginton Jon Marc | 12 Jun 2023 | 8 Jun 2023 | A-Award | director | 25,000 |
| STRO | Wigginton Jon Marc | 8 Jun 2022 | 6 Jun 2022 | A-Award | director: | 18,500 |
| STRO | Wigginton Jon Marc | 8 Jun 2022 | 6 Jun 2022 | A-Award | director | 18,500 |
| CMPI | Wigginton Jon Marc | 31 May 2022 | 31 May 2022 | D-Return | director | 20,061 |
| CMPI | Wigginton Jon Marc | 1 Feb 2022 | 30 Jan 2022 | A-Award | director | 20,061 |
| CMPI | Wigginton Jon Marc | 1 Feb 2022 | 30 Jan 2022 | director: | 0 | |
| STRO | Wigginton Jon Marc | 7 Jun 2021 | 3 Jun 2021 | A-Award | director | 18,500 |
| CGEM | Wigginton Jon Marc | 11 Jan 2021 | 7 Jan 2021 | A-Award | Chief Medical Officer | 116,666 |
| CGEM | Wigginton Jon Marc | 7 Jan 2021 | 7 Jan 2021 | Chief Medical Officer | 252,891 | |
| STRO | Wigginton Jon Marc | 1 Dec 2020 | 30 Nov 2020 | A-Award | director | 24,000 |
| STRO | Wigginton Jon Marc | 1 Dec 2020 | 30 Nov 2020 | director | 0 | |
| MGNX | Wigginton Jon Marc | 24 Feb 2020 | 20 Feb 2020 | A-Award | Sr VP, Clinical Dev. & CMO | 100,000 |
| MGNX | Wigginton Jon Marc | 25 Feb 2019 | 21 Feb 2019 | A-Award | Sr VP, Clinical Dev. & CMO | 90,000 |
| MGNX | Wigginton Jon Marc | 6 Mar 2018 | 2 Mar 2018 | A-Award | Sr VP, Clinical Dev. & CMO | 70,000 |
| MGNX | Wigginton Jon Marc | 27 Feb 2018 | 26 Feb 2018 | F-InKind | Sr VP, Clinical Dev. & CMO | 11,070 |
| MGNX | Wigginton Jon Marc | 18 Jan 2018 | 16 Jan 2018 | M-Exempt | Sr VP, Clinical Dev. & CMO | 2,476 |
| MGNX | Wigginton Jon Marc | 18 Jan 2018 | 17 Jan 2018 | M-Exempt | Sr VP, Clinical Dev. & CMO | 2,524 |